Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
Clinical trial NCT00005037 · COMPLETED
Trial details
- NCT number
- NCT00005037
- Sponsor
- Fox Chase Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-01-01
- Primary completion
- 2002-10-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.